From Scribes to Visit Operating Systems
Caroline Zhang, CEO of Knowtex, on going from AI medical scribe to AI lab
The real prize in clinical AI is not the note, it is owning the steps before and after the visit where money, orders, and treatment decisions actually move. Knowtex is built around that wider workflow. Its product spans chart prep, live documentation, coding, order staging, and clinical insights, which reflects what a scribe actually sees in practice, not just what gets typed into the final note.1 2 3 4
- A medical scribe sits inside more than note taking. In Zhang’s interview, the role included chart prep, order entry, coding, payer logic, and how doctors route patients to next steps like treatment changes or clinical trials. That makes scribing a front row seat into the full clinical workflow.1
- The market is already pushing note generation toward commodity pricing. Doximity rolled out Scribe free in July 2025, and OpenEvidence added free Visits, which means standalone documentation is harder to charge for. Vendors have to move into workflows that touch revenue, compliance, and clinical action.4 5 6
- That is also where enterprise buyers care most. Knowtex describes one platform for documentation, coding, orders, and EHR summarization, while peers like Abridge and Ambience are also expanding beyond ambient notes into health system workflows tied to billing, integration, and care operations.2 3 7
The category is heading toward full visit operating systems, not better dictation tools. The winners will be the companies that can turn a patient conversation and chart context into signed notes, cleaner codes, staged orders, and faster treatment decisions inside the EHR, with enough reliability that health systems standardize on them.2 3 6 7